• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Stem Cell M

  2026-05-25

  The referenced study establishes that BMP4-GPX4 signaling reduces ferroptosis in retinal ganglion cells and enhances the differentiation of transplanted retinal stem cells in a mouse model of high intraocular pressure glaucoma. This mechanistic insight provides a promising direction for therapies targeting oxidative stress and cell death in neurodegenerative retinal disease.

• a-MSH, amide: Integrative Insights for Pigmentation and Infl

  2026-05-25

  Explore the unique dual role of a-MSH, amide in pigmentation regulation and anti-inflammatory peptide research. This article delivers new scientific perspectives, advanced protocol guidance, and a bridge between melanogenesis control and inflammation pathways.

• Reliable Apoptosis Assays with BCL-XL Inhibitor A-1155463

  2026-05-24

  This in-depth guide addresses practical laboratory challenges in apoptosis research, cell viability, and drug resistance studies using the selective BCL-XL inhibitor A-1155463 (SKU B6163). Drawing on peer-reviewed evidence and validated protocols, it demonstrates how A-1155463 from APExBIO streamlines experimental design and enhances data reliability across oncology and hematological malignancy models.

• Partial β-Secretase Inhibition Preserves Synaptic Function i

  2026-05-23

  Satir et al. (2020) demonstrate that moderate β-secretase (BACE) inhibition can reduce amyloid β production by up to 50% without disrupting synaptic transmission in cultured neurons. These findings inform a nuanced approach to therapeutic targeting in Alzheimer’s disease, suggesting that partial inhibition may offer disease-modifying effects while minimizing adverse impacts on neural function.

• Ganetespib (STA-9090): Optimizing Hsp90 Inhibition in Cancer

  2026-05-22

  Ganetespib (STA-9090) stands out as a next-generation Hsp90 inhibitor, delivering nanomolar potency and unique workflow flexibility for cancer research. This guide details experimental setups, data-driven advantages, and troubleshooting essentials, with insights from recent discoveries in regulated cell death and unconventional secretion pathways.

• Estradiol Benzoate: Quantitative Agonism and Assay Optimizat

  2026-05-22

  Explore how Estradiol Benzoate serves as a precise estrogen receptor alpha agonist for advanced signaling research. This article uniquely bridges assay optimization, quantitative binding insights, and best-practice workflow design for hormone receptor studies.

• Strategic Leverage of 3X (DYKDDDDK) Peptide in Translational

  2026-05-21

  This article offers a mechanistic and strategic perspective on deploying the 3X (DYKDDDDK) Peptide in translational virology, focusing on its role in the affinity purification and immunodetection of FLAG-tagged proteins. We contextualize its value within emerging challenges, such as dissecting virus-host interactions exemplified by the ANKLE2–NS4A axis in Zika virus replication, and provide actionable guidance for researchers seeking to enhance workflow reliability and discovery potential.

• Thiothixene: Typical Antipsychotic Agent in Efferocytosis Wo

  2026-05-21

  Thiothixene bridges neuropharmacology and immunology by not only treating psychotic disorders but enhancing in vitro macrophage efferocytosis. This article details how to leverage its dual action in bench research, with workflow guidance and troubleshooting tips for reproducible results.

• Optimizing O-GlcNAcase Inhibition: Thiamet G (SKU B2048) in

  2026-05-20

  This article addresses laboratory challenges in O-GlcNAcylation research, focusing on optimizing assay reliability, data interpretation, and protocol design using Thiamet G (SKU B2048). Scenario-driven Q&A blocks offer evidence-based guidance for biomedical scientists, highlighting APExBIO's product advantages in workflow reproducibility, solubility, and validated use cases.

• β-Amanitin: Precision Tool for RNA Polymerase II Inhibition

  2026-05-20

  β-Amanitin is a potent bicyclic octapeptide toxin used in molecular biology for selective inhibition of RNA polymerase II. It enables high-specificity mRNA synthesis inhibition assays and advances toxicology studies of amatoxins. This article details its biochemical rationale, mechanism, and best-practice research workflows.

• Protease Inhibitors Suppress Light-Induced Stomatal Opening

  2026-05-19

  This study identifies specific protease inhibitors that significantly suppress blue light-induced stomatal opening in Commelina benghalensis. The findings advance our understanding of protease roles in guard cell signaling, offering new mechanistic insights and tools for plant physiology research.

• PTX3 Attenuates Glucocorticoid-Induced ONFH via TLR4/NF-κB-F

  2026-05-19

  The reference study demonstrates that pentraxin 3 (PTX3) alleviates glucocorticoid-induced osteonecrosis of the femoral head (ONFH) by modulating the TLR4/NF-κB/FGF21 signaling pathway. These findings highlight a novel mechanistic axis involving PTX3 and reveal new therapeutic angles for osteonecrosis and bone degeneration related to ER stress and inflammation.

• a-MSH, amide: Mechanisms and Innovations in Pigmentation Res

  2026-05-18

  Explore the multifaceted role of a-MSH, amide in pigmentation regulation research, focusing on its mechanistic actions and how it advances assay design compared to traditional approaches. Discover distinct scientific insights and practical guidance for leveraging this peptide in melanogenesis and anti-inflammatory studies.

• Foxp1 Suppresses Notch-Mediated EndMT to Limit Valve Calcifi

  2026-05-18

  This study demonstrates that endothelial-specific overexpression of Foxp1 inhibits Notch pathway activation and reduces endothelial-to-mesenchymal transition (EndMT), thereby attenuating valvular calcification in chronic kidney disease (CKD) models. The findings clarify mechanistic links between PTH-induced EndMT, Notch signaling, and valve pathology, highlighting Foxp1 as a potential regulatory target for cardiovascular complications in CKD.

• Re-Evaluating Aminopeptidase and ACE Inhibitor Selectivity i

  2026-05-17

  This article reviews a pivotal study comparing the inhibitory profiles of several metallopeptidase inhibitors—including ACE inhibitors—across key aminopeptidases in the mammalian cell surface zinc peptidase family. The findings clarify selectivity boundaries, inform the interpretation of pharmacological data, and guide researchers in designing experiments on peptide metabolism in cardiovascular, renal, and related disease models.

461 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page